$ALCO
ALICO, INC.

2023 Q3 Form 10-Q Financial Statement

#000095017023037564 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $680.0K $7.284M
YoY Change -34.04% -71.92%
Cost Of Revenue -$393.0K -$8.218M
YoY Change -101.71% -133.37%
Gross Profit $1.073M $15.50M
YoY Change -104.9% 1082.46%
Gross Profit Margin 157.79% 212.82%
Selling, General & Admin $2.537M $2.930M
YoY Change 5.71% 14.59%
% of Gross Profit 236.44% 18.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.797M $3.838M
YoY Change 1.17% 0.79%
% of Gross Profit 353.87% 24.76%
Operating Expenses $2.537M $2.930M
YoY Change 5.71% 14.59%
Operating Profit -$1.464M $12.57M
YoY Change -93.97% -1108.99%
Interest Expense -$1.235M -$1.196M
YoY Change 82.15% 40.05%
% of Operating Profit -9.51%
Other Income/Expense, Net -$44.00K $1.423M
YoY Change -88.97% -71.02%
Pretax Income $1.398M $14.00M
YoY Change -105.66% 281.96%
Income Tax $495.0K $1.923M
% Of Pretax Income 35.41% 13.74%
Net Earnings $940.0K $11.83M
YoY Change -104.46% 337.25%
Net Earnings / Revenue 138.24% 162.44%
Basic Earnings Per Share $1.56
Diluted Earnings Per Share $0.12 $1.56
COMMON SHARES
Basic Shares Outstanding 7.611M 7.605M
Diluted Shares Outstanding 7.605K

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.062M $1.592M
YoY Change 22.77% -76.82%
Cash & Equivalents $1.062M $1.592M
Short-Term Investments
Other Short-Term Assets $3.350M $1.861M
YoY Change 105.65% 2.14%
Inventory $52.48M $38.83M
Prepaid Expenses
Receivables $712.0K $4.363M
Other Receivables $1.200M $1.046M
Total Short-Term Assets $58.81M $47.70M
YoY Change 86.0% -8.78%
LONG-TERM ASSETS
Property, Plant & Equipment $361.8M $368.3M
YoY Change -2.85% -1.29%
Goodwill $2.246M $2.246M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.823M $2.895M
YoY Change -3.12% -12.35%
Total Long-Term Assets $369.5M $373.4M
YoY Change -2.14% -2.07%
TOTAL ASSETS
Total Short-Term Assets $58.81M $47.70M
Total Long-Term Assets $369.5M $373.4M
Total Assets $428.4M $421.1M
YoY Change 4.67% -2.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.311M $7.063M
YoY Change 87.49% 45.99%
Accrued Expenses $5.363M $5.428M
YoY Change -40.82% -40.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.566M $2.098M
YoY Change -15.45% -30.87%
Total Short-Term Liabilities $15.07M $15.39M
YoY Change -8.84% -27.4%
LONG-TERM LIABILITIES
Long-Term Debt $101.4M $120.7M
YoY Change -6.61% 15.59%
Other Long-Term Liabilities $369.0K $282.0K
YoY Change -15.17% -47.09%
Total Long-Term Liabilities $101.8M $282.0K
YoY Change 23297.47% -47.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.07M $15.39M
Total Long-Term Liabilities $101.8M $282.0K
Total Liabilities $178.0M $171.5M
YoY Change 10.96% 5.46%
SHAREHOLDERS EQUITY
Retained Earnings $243.8M $243.2M
YoY Change 0.13% -8.5%
Common Stock $28.46M $28.43M
YoY Change 0.93% 1.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $27.27M $27.44M
YoY Change -2.41% -2.32%
Treasury Stock Shares $811.0K
Shareholders Equity $245.0M $244.2M
YoY Change
Total Liabilities & Shareholders Equity $428.4M $421.1M
YoY Change 4.67% -2.88%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $940.0K $11.83M
YoY Change -104.46% 337.25%
Depreciation, Depletion And Amortization $3.797M $3.838M
YoY Change 1.17% 0.79%
Cash From Operating Activities -$5.634M $6.492M
YoY Change 31.97% 225.58%
INVESTING ACTIVITIES
Capital Expenditures $3.736M $4.478M
YoY Change -166.49% -197.58%
Acquisitions
YoY Change
Other Investing Activities $5.323M $2.871M
YoY Change 864.31% -53.13%
Cash From Investing Activities $1.597M -$1.607M
YoY Change -131.52% -204.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.144M -3.441M
YoY Change 814.29% -82.95%
NET CHANGE
Cash From Operating Activities -5.634M 6.492M
Cash From Investing Activities 1.597M -1.607M
Cash From Financing Activities 6.144M -3.441M
Net Change In Cash 2.107M 1.444M
YoY Change -124.32% -108.67%
FREE CASH FLOW
Cash From Operating Activities -$5.634M $6.492M
Capital Expenditures $3.736M $4.478M
Free Cash Flow -$9.370M $2.014M
YoY Change -794.07% -69.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000003545
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
0.625
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-261
dei Entity Registrant Name
EntityRegistrantName
ALICO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-0906081
dei Entity Address Address Line1
EntityAddressAddressLine1
10070 Daniels Interstate Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Myers
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33913
dei City Area Code
CityAreaCode
239
dei Local Phone Number
LocalPhoneNumber
226-2000
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
ALCO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7610551
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1592000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
865000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4363000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
324000
CY2023Q2 us-gaap Inventory Net
InventoryNet
38833000
CY2022Q3 us-gaap Inventory Net
InventoryNet
27682000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1046000
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1116000
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
130000
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
205000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1731000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1424000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
47695000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
31616000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368290000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
372479000
CY2023Q2 us-gaap Goodwill
Goodwill
2246000
CY2022Q3 us-gaap Goodwill
Goodwill
2246000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2895000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2914000
CY2023Q2 us-gaap Assets
Assets
421126000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7063000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3366000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5428000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2098000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3035000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
800000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1062000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15389000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16525000
CY2023Q2 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
102791000
CY2022Q3 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
103661000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
653000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
748000
CY2023Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102138000
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102913000
CY2023Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
17910000
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4928000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35755000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35589000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
282000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
435000
CY2023Q2 us-gaap Liabilities
Liabilities
171474000
CY2022Q3 us-gaap Liabilities
Liabilities
160390000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7605189
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7586995
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8416000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
8416000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20011000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19784000
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
810956
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
27444000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
27948000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
243245000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
243490000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
244228000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
243742000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
5424000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
5123000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249652000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
421126000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409255000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7284000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25938000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39166000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90916000
CY2023Q2 alco Operating Expenses Income
OperatingExpensesIncome
-8218000
CY2022Q2 alco Operating Expenses Income
OperatingExpensesIncome
24627000
alco Operating Expenses Income
OperatingExpensesIncome
33793000
alco Operating Expenses Income
OperatingExpensesIncome
83795000
CY2023Q2 us-gaap Gross Profit
GrossProfit
15502000
CY2022Q2 us-gaap Gross Profit
GrossProfit
1311000
us-gaap Gross Profit
GrossProfit
5373000
us-gaap Gross Profit
GrossProfit
7121000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2930000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2557000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8106000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7679000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12572000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1246000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2733000
us-gaap Operating Income Loss
OperatingIncomeLoss
-558000
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1196000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
854000
us-gaap Interest Expense Debt
InterestExpenseDebt
3618000
us-gaap Interest Expense Debt
InterestExpenseDebt
2625000
CY2023Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2605000
CY2022Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
5755000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
7368000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
40804000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1423000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4910000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3794000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
38198000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13995000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3664000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1061000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37640000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1923000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1002000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
306000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4281000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
12072000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
2662000
us-gaap Profit Loss
ProfitLoss
755000
us-gaap Profit Loss
ProfitLoss
33359000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-44000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-140000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-180000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
11832000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2706000
us-gaap Net Income Loss
NetIncomeLoss
895000
us-gaap Net Income Loss
NetIncomeLoss
33539000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.44
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.56
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.44
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7605
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7570
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7599
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7551
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7605
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7589
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7599
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7561
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
237321000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
12072000
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2023Q2 us-gaap Dividends
Dividends
380000
CY2023Q2 alco Noncontrolling Interest Increase From Contributions From Noncontrolling Interest
NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterest
441000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249652000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
us-gaap Profit Loss
ProfitLoss
755000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Dividends
Dividends
1140000
alco Noncontrolling Interest Increase From Contributions From Noncontrolling Interest
NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterest
441000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249652000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
274068000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
2662000
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2022Q2 us-gaap Dividends
Dividends
3792000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
295000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
273537000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250117000
us-gaap Profit Loss
ProfitLoss
33359000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
us-gaap Dividends
Dividends
11338000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
465000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
273537000
us-gaap Profit Loss
ProfitLoss
755000
us-gaap Profit Loss
ProfitLoss
33359000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11685000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11476000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
106000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
214000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7368000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
40804000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
5535000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2228000
alco Inventory Net Realizable Value Adjustment
InventoryNetRealizableValueAdjustment
1616000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
166000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4758000
us-gaap Share Based Compensation
ShareBasedCompensation
731000
us-gaap Share Based Compensation
ShareBasedCompensation
934000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-4000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4039000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1509000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12767000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4376000
alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-307000
alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-428000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-70000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3233000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-315000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
556000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3355000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3618000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3138000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-467000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
489000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-618000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10792000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12923000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15112000
alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
77000
alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
136000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7583000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
42718000
alco Proceeds From Payments To Acquire Notes Receivable
ProceedsFromPaymentsToAcquireNotesReceivable
-570000
alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
-269000
alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
-65000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5718000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27535000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
51953000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
46470000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
64935000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
46470000
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
1807000
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
18839000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
441000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
465000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4553000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11310000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7063000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29684000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
727000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8643000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
865000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
886000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1592000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9529000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.</span></p>
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are generally collected or paid thirty to sixty days after final market pricing is published.
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7284000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25938000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39166000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90916000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts have been reclassified in the accompanying Financial Statements for consistent presentation to the current period. These reclassifications had no impact on net income, equity, cash flows or working capital as previously reported.</span></p>
CY2023Q2 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
37374000
CY2022Q3 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
26717000
CY2023Q2 us-gaap Other Inventory
OtherInventory
1459000
CY2022Q3 us-gaap Other Inventory
OtherInventory
965000
CY2023Q2 us-gaap Inventory Net
InventoryNet
38833000
CY2022Q3 us-gaap Inventory Net
InventoryNet
27682000
CY2022 us-gaap Loss From Catastrophes
LossFromCatastrophes
14900000
us-gaap Loss From Catastrophes
LossFromCatastrophes
0
CY2023Q2 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
16643000
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
21403000
CY2022 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1123000
CY2021 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4299000
CY2020 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1315000
CY2022Q4 us-gaap Area Of Land
AreaOfLand
85
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
438900
CY2022Q4 alco Land Sold Price Per Acre
LandSoldPricePerAcre
5161
CY2022Q1 us-gaap Area Of Land
AreaOfLand
93
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2022Q1 alco Lease Commencing Date
LeaseCommencingDate
2022-01-01
CY2022Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-01-01
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
1860
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Company had granted to Mr. Kiernan an option to purchase the Land from the Company, exercisable only during the one-year period January 1, 2022 through January 1, 2023
CY2022Q1 alco Option Amount To Repurchase
OptionAmountToRepurchase
480000
CY2022Q1 alco Repurchase Price Per Acre
RepurchasePricePerAcre
5161
CY2022Q3 us-gaap Area Of Land
AreaOfLand
85
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368290000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
372479000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2098000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3035000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20945000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3035000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3035000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
90651000
CY2023Q2 alco Long Term Debt And Line Of Credit
LongTermDebtAndLineOfCredit
122799000
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1196000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
854000
us-gaap Interest Expense Debt
InterestExpenseDebt
3618000
us-gaap Interest Expense Debt
InterestExpenseDebt
2625000
CY2023Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
391000
CY2022Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
395000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1005000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1026000
CY2023Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
1587000
CY2022Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
1249000
us-gaap Interest Costs Incurred
InterestCostsIncurred
4623000
us-gaap Interest Costs Incurred
InterestCostsIncurred
3651000
us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.0385
CY2022Q3 alco Debt Instrument Covenant Minimum Debt Coverage Ratio
DebtInstrumentCovenantMinimumDebtCoverageRatio
1.10
CY2022Q3 alco Debt Instrument Covenant Minimum Tangible Net Worth
DebtInstrumentCovenantMinimumTangibleNetWorth
160000000
CY2022 alco Debt Instrument Covenant Percentage Annual Increase
DebtInstrumentCovenantPercentageAnnualIncrease
0.10
CY2022 alco Debt Instrument Covenant Minimum Tangible Networth Annual Increase
DebtInstrumentCovenantMinimumTangibleNetworthAnnualIncrease
174462000
CY2023Q2 alco Lineof Credit Facility Covenant Terms Minimum Current Ratio
LineofCreditFacilityCovenantTermsMinimumCurrentRatio
1.50
CY2023Q2 alco Debt Instrument Covenant Maximum Capital Expenditure
DebtInstrumentCovenantMaximumCapitalExpenditure
30000000
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0535
CY2023Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1423000
CY2022Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2024000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
998000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
764000
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1747000
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1713000
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
380000
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
3793000
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
226000
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
345000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
425000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
303000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
229000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
120000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5428000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
580314
CY2021Q4 us-gaap Area Of Land
AreaOfLand
1638
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1400000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4900000
CY2022 alco Deferred Tax Assets Charitable Contribution Utilized
DeferredTaxAssetsCharitableContributionUtilized
500000
CY2022Q3 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
5800000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
11832000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2706000
us-gaap Net Income Loss
NetIncomeLoss
895000
us-gaap Net Income Loss
NetIncomeLoss
33539000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7605
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7570
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7599
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7551
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7605
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7589
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7599
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7561
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.44
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.44
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7284000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25938000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39166000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90916000
CY2023Q2 alco Operating Expenses Income
OperatingExpensesIncome
-8218000
CY2022Q2 alco Operating Expenses Income
OperatingExpensesIncome
24627000
alco Operating Expenses Income
OperatingExpensesIncome
33793000
alco Operating Expenses Income
OperatingExpensesIncome
83795000
CY2023Q2 us-gaap Gross Profit
GrossProfit
15502000
CY2022Q2 us-gaap Gross Profit
GrossProfit
1311000
us-gaap Gross Profit
GrossProfit
5373000
us-gaap Gross Profit
GrossProfit
7121000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3838000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3808000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11685000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11476000
CY2023Q2 us-gaap Assets
Assets
421126000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
30000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
31000
us-gaap Operating Lease Cost
OperatingLeaseCost
91000
us-gaap Operating Lease Cost
OperatingLeaseCost
109000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M23D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0180
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
137000000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
450000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
505000000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
27948000
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
18194
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-504000
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
810956
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
27444000
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
4380000

Files In Submission

Name View Source Status
0000950170-23-037564-index-headers.html Edgar Link pending
0000950170-23-037564-index.html Edgar Link pending
0000950170-23-037564.txt Edgar Link pending
0000950170-23-037564-xbrl.zip Edgar Link pending
alco-20230630.htm Edgar Link pending
alco-20230630.xsd Edgar Link pending
alco-ex31_1.htm Edgar Link pending
alco-ex31_2.htm Edgar Link pending
alco-ex32_1.htm Edgar Link pending
alco-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
alco-20230630_cal.xml Edgar Link unprocessable
alco-20230630_def.xml Edgar Link unprocessable
alco-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
alco-20230630_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
alco-20230630_lab.xml Edgar Link unprocessable